Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.

Founded in 1996, Alexandria Venture Investments is a venture capital firm specializing in seed, early stage, and growth capital investments. It focuses on the healthcare sector, including biopharma, diagnostics, life sciences, research tools, agrifoodtech, agtech, and technology.

Founded in 2005, Y Combinator is a California-based startup accelerator and early-stage venture capital firm. It provides funding, mentorship, and resources to early-stage companies across various industries, with a focus on technology, healthcare, and finance. The organization helps founders refine their business models and products through an intensive three-month program in Silicon Valley, culminating in Demo Day presentations to investors.

Founded in 1986, ARCH Venture Partners is a venture capital firm specializing in investments that bring innovations in life sciences to market. It focuses on companies co-founded by scientists and entrepreneurs, with a strong track record in commercializing technologies from academic research institutions and national laboratories.

Founded in Boston in 2004, RA Capital is an investment firm specializing in life sciences and drug development. Its team, with backgrounds in biology, chemistry, medicine, and industry experience, invests in early-stage companies with promising technologies and products across healthcare and life science sectors.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

Founded in 1999, Perceptive Advisors is a New York-based investment firm focused on the life sciences sector. It invests across various stages of company development, from seed to late-stage ventures and public equities, with a typical investment size ranging from $10 million to $200 million. The firm employs long/short equity strategies and conducts in-house research to identify promising opportunities in biotechnology, pharmaceuticals, life sciences, and healthcare services.

IndieBio is an accelerator that supports startups using biology to solve major problems, delivering four-month programs for companies and teams with ideas. Based in San Francisco with an office in New York, it focuses on life sciences, biotechnology and synthetic biology, investing in seed and early-stage ventures that place biology at the core of their technology across products, processes and software. The program favors teams with two or more co-founders and generally provides equity-based funding in the early stages, often combining direct investments with additional financing options. Founded in 2014, IndieBio operates within the SOSV accelerator network, a global platform that supports portfolio companies through mentorship, resources and cross-border programs.

Founded in Paris in 1972, Sofinnova Partners is a venture capital firm dedicated to life sciences investments. With over €2 billion under management, the firm actively partners with entrepreneurs from seed to later-stage, focusing on biopharmaceuticals, medical devices, and industrial biotechnology. Sofinnova proactively sources deals, often leading Round A financings, and plays an active role in portfolio companies until exit.

Novo Holdings is a Danish holding and investment firm managing the assets of the Novo Nordisk Foundation. Established in 1999, it invests globally in life science companies at all stages of development, with a portfolio also including equities, bonds, real estate, and infrastructure.

Google is a multinational technology company renowned for its search engine, offering services such as Gmail, Google Drive, Google Docs, and YouTube. It specializes in advertising solutions through Google Ads and mobile operating systems with Android, while actively innovating in artificial intelligence and machine learning.

Founded in 2004, Khosla Ventures is a venture capital firm based in Menlo Park, California. The firm invests in early-stage technology companies across various sectors including AI, climate, enterprise, consumer, fintech, digital health, medtech, therapeutics, and frontier technology.

Invus Financial Advisors, LLC is an employee-owned investment firm based in New York, founded in 2006. The firm specializes in private equity investments and manages pooled investment vehicles, including hedge funds and funds of funds. Invus focuses on making direct and indirect investments in special situations, venture capital, and growth equity stages, with an emphasis on smaller companies and opportunistic co-investments. The firm adopts a flexible approach, recognizing the uniqueness of each company and the complexities of business transformation. Invus maintains a long-term commitment to its investments, aligning its incentives with those of its partners. With a history of empowering owner-managers since 1985 and a strong backing from a group of European families, Invus Financial Advisors manages over $4 billion in an evergreen fund and operates additional offices in London, Paris, and Hong Kong.

Founded in 1999, Versant Ventures is a global healthcare investment firm dedicated to supporting exceptional entrepreneurs building innovative companies. With over $2 billion under management and offices across North America and Europe, the firm invests across all stages of healthcare company development, with a focus on novel therapeutics. Versant's team, with deep investment, operating, and scientific expertise, takes a hands-on approach to company building.

Casdin Capital is a New York‑based investment firm founded in 2012 by Eli Casdin. The firm specializes in fundamental research and long‑short equity strategies focused on the life sciences and healthcare sectors, including oncology, digital health, and agtech. In addition to its public‑market fund, Casdin Capital invests in early‑stage to late‑stage private companies within these industries. It operates as a Registered Investment Adviser and, as of October 2020, managed approximately $2.2 billion in assets.

The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

Novartis is a global healthcare company based in Switzerland, providing innovative medicines and solutions to address evolving patient needs worldwide. With over 100,000 employees across 140 countries, they focus on discovering new treatments in areas such as oncology, immunology, neuroscience, and cardiovascular diseases.

The California Institute for Regenerative Medicine (CIRM) was established in 2005 following the passage of Proposition 71, which aimed to fund stem cell research at California universities and research institutions. With a mandate to support and advance stem cell research and regenerative medicine, CIRM focuses on developing cures, therapies, diagnostics, and research technologies that address chronic diseases and injuries. The organization operates under stringent ethical and medical standards, ensuring that its initiatives contribute positively to human health. CIRM plays a pivotal role in facilitating research through grants and loans, thereby fostering innovation and collaboration within the scientific community. Its efforts are directed towards alleviating human suffering and improving health outcomes through advancements in regenerative medicine.

T. Rowe Price Group is a global investment management firm serving individuals, institutions, and retirement plans. It launches and manages equity and fixed income mutual funds and provides separate accounts and other advisory services to clients. The firm invests in public markets worldwide, using a combination of fundamental and quantitative analysis with a bottom-up approach, supported by in-house and external research. It emphasizes socially responsible investing with a focus on environmental, social, and governance factors. Founded in 1937, the company is headquartered in Baltimore and maintains a worldwide presence with offices across North America, Europe, Asia, and the Middle East.

Established in 2000 by Bill and Melinda Gates, this foundation is dedicated to enhancing healthcare, reducing extreme poverty globally, and expanding educational opportunities. It operates regionally with offices in Seattle, Washington D.C., New Delhi, Beijing, and London.

Founded in 2011, Foresite Capital is a healthcare and life sciences investment firm based in Larkspur, California. It employs rigorous scientific and data-driven approaches to invest in promising healthcare businesses across various stages, with a focus on companies employing tools of data science and machine intelligence.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, with offices in San Francisco. Founded in 1996, it targets investments in technology and life science companies across the United States and Europe, supporting startups from early formation to profitable growth. The firm's healthcare and biotechnology focus encompasses digital health, consumer-centric care delivery, patient-provider solutions, data science and analytics, as well as therapeutics, genomics and other life science platforms. It backs companies across business-to-business and business-to-consumer models, software as a service, healthcare information technology and health tech sectors, partnering with repeat entrepreneurs to build durable, scale-ready businesses.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Founded in 1934, Janus Henderson Investors is a global asset management firm headquartered in London. It specializes in delivering investment performance and services to institutional, retail, and high-net-worth clients across various asset classes such as equities, fixed income, property, and alternatives.

Founded in 1980, Atlas Venture is an early-stage venture capital firm based in Cambridge, Massachusetts. It focuses on creating and investing in biotech startup companies led by promising entrepreneurs, with a seed-led venture creation strategy that rigorously selects compelling opportunities to build scalable businesses in life sciences innovation.

Founded in 2007, Innovate UK is a non-profit organization based in Swindon, UK. It supports businesses across various economic sectors by offering funding services to promote science and technology innovations.

Cormorant Asset Management, established in 2013 and headquartered in Boston, Massachusetts, is an employee-owned hedge fund sponsor. It offers services to pooled investment vehicles, specializing in investments across both public and private markets within the biotechnology and life sciences sectors.

Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.

Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. It invests globally in technology and healthcare sectors, supporting entrepreneurs with its extensive domain expertise and relationships.

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Viking Global Investors, established in 1999, is a privately owned hedge fund sponsor with headquarters in Greenwich, Connecticut. It manages over $20 billion across long-short equity and long-only strategies, investing globally in public equity and fixed income markets. The firm employs fundamental analysis, utilizing both in-house and external research, to make strategic investments across diverse sectors. With additional offices in New York, Hong Kong, and London, Viking Global Investors provides services primarily to pooled investment vehicles.

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines across neuroscience, cardiometabolic, cancer, and immunology. It operates manufacturing and distribution facilities in the United States, Puerto Rico, and 25 other countries, with products sold in about 135 countries. Its portfolio includes Verzenio for cancer; Mounjaro and Zepbound for cardiometabolic indications; Jardiance and Trulicity; Humalog and Humulin for diabetes; and Taltz and Olumiant for immunology.

Redmile Group, established in 2007, is a private equity firm headquartered in San Francisco with an additional office in New York. The company specializes in healthcare investments, focusing on venture capital opportunities within the sector.

Sanofi is a global pharmaceutical company headquartered in Paris that researches, develops, manufactures, and markets medicines and vaccines for a broad range of diseases. Its portfolio covers diabetes, oncology, immunology, cardiovascular diseases, and rare disorders, along with consumer healthcare products. Sanofi pursues innovation across biologics and small-molecule therapies and maintains a robust vaccine program to address infectious diseases. The company emphasizes patient-oriented research and collaborates with partners to bring new treatments to patients worldwide.

Kurma Partners, established in 2009, is a Paris-based private equity and venture capital firm specializing in early-stage investments in healthcare and biotechnology sectors across Europe. The company focuses on financing innovation from pre-creation to development capital, supporting therapeutic and medical innovations, and collaborating with leading research institutes and hospitals. Kurma Partners manages several funds, including Kurma Biofund I, II, and Kurma Diagnostics, making it a significant player in European healthcare financing.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Founded in 1928, Wellington Management is a global investment management firm headquartered in Boston, Massachusetts. The company offers a wide range of investment approaches, including equity, fixed income, currency, commodity, and alternative markets, as well as asset allocation, multi-manager, and specialty strategies to meet the needs of institutional clients.

Deerfield Management is a New York-based investment firm established in 1994 that focuses on healthcare. It operates across investment, information, and philanthropy to support the healthcare ecosystem. The firm provides private and public investments and offers long-term, structured capital to both public and private healthcare companies. Its portfolio spans life sciences, medical devices, diagnostics, digital health, and health services. As an investment adviser, it seeks opportunities in healthcare products and services and aims to accelerate innovation by combining capital with industry insight.

Forbion is a venture capital firm based in Naarden, Netherlands, established in 2006. It specializes in early-stage investments within the life sciences and MedTech sectors, focusing on companies involved in drug development and addressing critical medical needs. The firm has a team of nine investment professionals and has built a strong track record since the late 1990s, with successful investments in various notable companies. Forbion manages assets exceeding €400 million across three active funds and co-manages BioGeneration Ventures, which targets academic spin-outs and seed investments in the Netherlands. The firm continues to play a significant role in advancing innovative healthcare solutions through its strategic investments.

Founded in 2006, Qiming Venture Partners is a leading China-based venture capital firm with offices across China and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries.

Leaps by Bayer is the corporate venture capital arm of Bayer. Established in 2015 and headquartered in Leverkusen, Germany, it invests in life sciences, including healthcare, biotechnology, and agriculture. The firm seeks long-term, disruptive technologies and supports innovations with potential for significant societal impact.

Northpond Ventures is a venture capital firm based in Bethesda, Maryland, with additional offices in San Francisco and Cambridge. Founded in 2018, the firm specializes in growth capital investments across various sectors, including life sciences, biotechnology, diagnostics, digital health, and emerging technologies. Northpond Ventures aims to support innovative companies that are poised to make significant advancements in healthcare and technology, with a focus on building a better future through its strategic investments. As a Registered Investment Adviser, the firm is committed to fostering developments in therapeutics, artificial intelligence, machine learning, and medical technology.

Mission BioCapital is a life science venture capital firm investing in early-stage companies within the biotechnology sector. Founded in Cambridge, Massachusetts in 2009, the company is known for its experienced leadership team and deep support provided to portfolio companies.

Sequoia Capital is a global venture capital firm, founded in 1972, specializing in early-stage and growth investments across technology, healthcare, and consumer sectors. With offices worldwide, Sequoia manages multiple funds and has invested in over 350 companies that have become public or achieved significant valuations.

Founded by Marc Andreessen and Ben Horowitz in 2009, Andreessen Horowitz is a venture capital firm investing primarily in software businesses. It focuses on seed to late-stage investments across sectors such as consumer internet, business internet, mobile software, infrastructure, enterprise services, and fintech.

Surveyor Capital is a fundamental equities business that operates sector-aligned investment teams focusing on market neutral strategies. The company aims to generate alpha by gaining a deep understanding of each company's strategy, management teams, performance drivers, and industry trends over the medium and long term. With a focus on fundamental analysis, Surveyor Capital strives to achieve success through a comprehensive approach to investment in the equities market.

Founded in 1969, Venrock is a venture capital firm that partners with entrepreneurs to build successful technology and healthcare companies. Notable portfolio companies include Apple Computer, Athenahealth, Check Point Software, and Illumina.

Founded in 2011, DCVC is a venture capital firm based in Palo Alto, California. The firm invests in early-stage companies utilizing deep tech to solve complex problems across sectors such as artificial intelligence, exascale computing, climate, engineering, materials science, robotics, space, water, biology, defense, and security.

Founded in 2009, RTW Investments is a global investment firm headquartered in New York with offices in London and Shanghai. It primarily focuses on the life sciences, big data, and digital health sectors across the United States, Europe, and beyond.